PTJ
CLOV icon

Paul Tudor Jones’s Clover Health Investments CLOV Stock Holding History

Paul Tudor Jones’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
276,123
+84,762
+44% +$288K ﹤0.01% 2163
2026
Q1 		$337K Sell
191,361
-3,519
-2% -$7.63K ﹤0.01% 3066
2025
Q4 		$458K Buy
+194,880
New +$533K ﹤0.01% 2768
2025
Q3 		– Sell
-610,619
Closed -$1.7M – 3419
2025
Q2 		$1.7M Buy
610,619
+117,894
+24% +$388K ﹤0.01% 1772
2025
Q1 		$1.77M Buy
+492,725
New +$1.98M 0.01% 1434
2024
Q4 		– Sell
-1,462,558
Closed -$4.12M – 3066
2024
Q3 		$4.12M Buy
+1,462,558
New +$3.35M 0.02% 802
2022
Q2 		– Sell
-115,512
Closed -$410K – 2150
2022
Q1 		$410K Buy
+115,512
New +$335K 0.01% 1386
2021
Q3 		– Sell
-52,152
Closed -$695K – 2489
2021
Q2 		$695K Buy
+52,152
New +$512K 0.01% 1026

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paul Tudor Jones's CLOV Position: Q2 2026 in Review

Paul Tudor Jones increased its Clover Health Investments (CLOV) stake by 44% in Q2 2026, buying an estimated $288K and bringing the position to 276,123 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Paul Tudor Jones first reported a position in CLOV in Q2 2021 and has held it in 8 quarters since. The position peaked at $4.12M in Q3 2024. 224 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Paul Tudor Jones held 276,123 shares of Clover Health Investments worth $1.45M as of Q2 2026.
  • Paul Tudor Jones bought 84,762 Clover Health Investments shares in Q2 2026, an estimated $288K.
  • Clover Health Investments made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2163 holding.
  • Paul Tudor Jones first reported a position in Clover Health Investments in Q2 2021 and has held it in 8 quarters since.
  • Paul Tudor Jones's Clover Health Investments position peaked at $4.12M in Q3 2024.
  • 224 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.